Midregional pro-adrenomedullin and matrix metalloproteinase-2 levels in intrauterine growth restriction and small gestational age pregnancies: biochemical diagnostic difference-Reference-Cited by-同舟云学术

Midregional pro-adrenomedullin and matrix metalloproteinase-2 levels in intrauterine growth restriction and small gestational age pregnancies: biochemical diagnostic difference

Published:2020-11-22 Issue:12 Volume:34 Page:1999-2005
ISSN:1476-7058
Container-title:The Journal of Maternal-Fetal & Neonatal Medicine
language:en
Short-container-title:The Journal of Maternal-Fetal & Neonatal Medicine

Author:

Şahin Banuhan¹^ORCID,Soyer-Çalışkan Canan²^ORCID,Çelik Samettin²^ORCID,Hatırnaz Şafak³^ORCID,Tinelli Andrea⁴⁵⁶^ORCID

Affiliation:

1. Gynecology and Obstetrics Department, Amasya University Sabuncuoglu Serefeddin Training and Research Hospital, Amasya, Turkey

2. Gynecology and Obstetrics Department, Samsun Training and Research Hospital, Samsun, Turkey

3. IVF Unit, Department of Gynecology and Obstetrics, Medicana International Hospital, Samsun, Turkey

4. Department of Obstetrics and Gynecology, “Verisdelli Ponti” Hospital, Scorrano, Lecce, Italy

5. Division of Experimental Endoscopic Surgery, Imaging, Technology and Minimally Invasive Therapy, Vito Fazzi Hospital, Lecce, Italy

6. Laboratory of Human Physiology, PhystechBioMed School, Faculty of Biological & Medical Physics, Moscow Institute of Physics and Technology (State University), Dolgoprudny, Moscow Region, Russia

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/14767058.2020.1846707

Reference33 articles.

1. Consensus definition of fetal growth restriction: a Delphi procedure

2. Validation of Delphi procedure consensus criteria for defining fetal growth restriction

3. Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy

4. Maternal serum ferritin as a clinical tool at 34–36 weeks’ gestation for distinguishing subgroups of fetal growth restriction

5. Intrauterine Growth Restriction: Antenatal and Postnatal Aspects